Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Northern Trust
NTRS
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By geography
See full
Non-U.S.
34%
0.0%
Other financials
Income statement
See full
Revenue
$2.2B
+13.7%
Net income
$525.5M
+34.1%
EPS (diluted)
$2.71
+42.6%
Balance sheet
See full
Cash & equivalents
$6.4B
-2.2%
Total debt
$624.4M
-3.8%
Total equity
$13.0B
+0.8%
Total assets
$174.57B
+5.8%
Cash flow
See full
Operating cash flow
-$320.0M
-112%
CapEx
$9.4M
-24.2%
Free cash flow
-$329.4M
-112%
Valuation
See full
Market cap
$32.17B
+33.6%
P/E
17.2×
+3.3×
P/S
3.9×
-1.4×
Profitability
See full
Net margin
22.8%
-3.9pp
FCF margin
65.1%
-24.5pp
Returns & leverage
See full
Return on equity
14.5%
-3.2pp
Debt / equity
0×
0.0×